Afsaneh Alavi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Afsaneh Alavi has a total of 612 co-authors. Here are the top co-authors by number of shared publications:
- Michelle A. Lowes
The Rockefeller University, New York City, USA
13 shared publications Robert S. Kirsner
Dr Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, Florida
13 shared publications- Angelo Valerio Marzano
Dermatology Unit Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milan Italy
9 shared publications Austin Todd
Mayo Clinic Department of Dermatology Rochester Minnesota USA
9 shared publicationsR. Gary Sibbald
Department of Medicine (Dermatology), University of Toronto, Toronto, Ontario, Canada; Department of Public Health, University of Toronto, Toronto, Ontario, Canada
9 shared publications- Vincent Piguet
Division of Dermatology, Department of Medicine, Women’s College Hospitals, Toronto, ON, Canada
8 shared publications
Latest Publications
- 20 October 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 530
Insights from HS PROGRESS, a longitudinal registry of patients with Hidradenitis Suppurativa
- 20 October 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 530
Insights from HS PROGRESS, a longitudinal registry of patients with Hidradenitis Suppurativa
- 18 September 2026
- Published by Wolters Kluwer Health in Advances in Skin & Wound Care
- Vol. 39 (9) , 462-475
Hidradenitis Suppurativa: Part of a Tetrad of Follicular Occlusion Disorders
Follicular occlusion disorders (FOD) represent a tetrad of chronic, recurrent inflammatory conditions united by a common pathophysiologic mechanism: follicular hyperkeratosis leading to occlusion, rupture, and subsequent abscess or sinus tract formation. First conceptualized as a triad in the 1950s and later expanded to a tetrad in the 1970s, this grouping includes hidradenitis suppurativa (HS), acne conglobata (AC), dissecting cellulitis of the scalp (DCS), and pilonidal sinus (PS). Despite their shared pathogenesis, each condition carries distinct clinical features, epidemiological profiles, and management considerations. This article aims to provide a comprehensive review of FOD, with a primary emphasis on HS (the most prevalent of the disorders). Hidradenitis suppurativa is a debilitating disease affecting ∼1% of the global population, predominantly in females, and the diagnosis is often delayed by 7 or more years. Multiple genes are linked to FOD patients with a positive familial history in 35% to 40%, along with lifestyle factors (smoking, alcohol consumption, and obesity). Key inflammatory mediators, including TNF-α, IL-1β, and IL-17, drive the chronic tissue destruction characteristic of FOD, frequently resulting in scarring, lymphedema, and significant psychosocial impairment. Wound care is critical and often underemphasized in disease management. This article outlines evidence-informed wound care strategies for both nonsurgical and postsurgical presentations, including dressing selection, exudate and odor management, pain and itch control, infection management, and the emerging role of intravenous ertapenem as rescue therapy. An interprofessional approach, integrating dermatology, surgery, wound care nursing, and psychosocial support, is emphasized throughout as essential to improving patient outcomes and quality of life. GENERAL PURPOSE: To increase clinicians’ understanding of follicular occlusion disorders including the associated risk factors, clinical manifestations, and evidence-based approaches for management. TARGET AUDIENCE: This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and registered nurses with an interest in skin and wound care. LEARNING OBJECTIVES/OUTCOMES: After participating in this educational activity, the participant will: Assess clinical characteristics of each follicular occlusion disorder Evaluate the basic disease mechanisms for follicular occlusion disorders Describe principal disease burdens that require wound care attention Identify the unique wound care strategies and follicular occlusion disorder challenges JOURNAL/aswca/04.03/00129334-202610000-00004/figure1/v/2026-09-18T181327Z/r/image-jpeg
- 18 September 2026
- Published by Wolters Kluwer Health in Advances in Skin & Wound Care
- Vol. 39 (9) , 462-475
Hidradenitis Suppurativa: Part of a Tetrad of Follicular Occlusion Disorders
Follicular occlusion disorders (FOD) represent a tetrad of chronic, recurrent inflammatory conditions united by a common pathophysiologic mechanism: follicular hyperkeratosis leading to occlusion, rupture, and subsequent abscess or sinus tract formation. First conceptualized as a triad in the 1950s and later expanded to a tetrad in the 1970s, this grouping includes hidradenitis suppurativa (HS), acne conglobata (AC), dissecting cellulitis of the scalp (DCS), and pilonidal sinus (PS). Despite their shared pathogenesis, each condition carries distinct clinical features, epidemiological profiles, and management considerations. This article aims to provide a comprehensive review of FOD, with a primary emphasis on HS (the most prevalent of the disorders). Hidradenitis suppurativa is a debilitating disease affecting ∼1% of the global population, predominantly in females, and the diagnosis is often delayed by 7 or more years. Multiple genes are linked to FOD patients with a positive familial history in 35% to 40%, along with lifestyle factors (smoking, alcohol consumption, and obesity). Key inflammatory mediators, including TNF-α, IL-1β, and IL-17, drive the chronic tissue destruction characteristic of FOD, frequently resulting in scarring, lymphedema, and significant psychosocial impairment. Wound care is critical and often underemphasized in disease management. This article outlines evidence-informed wound care strategies for both nonsurgical and postsurgical presentations, including dressing selection, exudate and odor management, pain and itch control, infection management, and the emerging role of intravenous ertapenem as rescue therapy. An interprofessional approach, integrating dermatology, surgery, wound care nursing, and psychosocial support, is emphasized throughout as essential to improving patient outcomes and quality of life. GENERAL PURPOSE: To increase clinicians’ understanding of follicular occlusion disorders including the associated risk factors, clinical manifestations, and evidence-based approaches for management. TARGET AUDIENCE: This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and registered nurses with an interest in skin and wound care. LEARNING OBJECTIVES/OUTCOMES: After participating in this educational activity, the participant will: Assess clinical characteristics of each follicular occlusion disorder Evaluate the basic disease mechanisms for follicular occlusion disorders Describe principal disease burdens that require wound care attention Identify the unique wound care strategies and follicular occlusion disorder challenges JOURNAL/aswca/04.03/00129334-202610000-00004/figure1/v/2026-09-18T181327Z/r/image-jpeg
- 9 September 2026
- Published by Wiley in Pediatric Dermatology
Associations of Active and Passive Smoke Exposure and Hidradenitis Suppurativa in the Pediatric Population: A Case–Control Study
Background: Hidradenitis suppurativa (HS) is an inflammatory condition associated with cysts of the folliculopilosebaceous unit primarily affecting intertriginous areas. HS has been correlated with smoke exposure in the adult population, but there is a knowledge gap in understanding its effect in pediatric and adolescent patients. This study assesses correlations between active and passive smoke exposure and the development of HS in the pediatric and adolescent population. Methods: A retrospective case–control study was conducted at Mayo Clinic (2010–2023) of patients diagnosed with HS before the age of 18 years who were age‐, sex‐, and race‐matched to healthy controls in a 1:3 ratio, analyzed using Fisher exact for categorical variables and Kruskal–Wallis for continuous. Results: One hundred and seventy‐four cases and 522 controls met inclusion criteria. The prevalence of active and passive smoke exposure was significantly higher in patients with HS compared to controls ( p = 0.001), with passive smoke accounting for 64.6% ( N = 31/48) of smoke exposure in patients with HS. Smoke exposure was associated with a significant increase in the odds of an HS diagnosis, with an odds ratio of 4.8 (95% CI: 3.06–7.61) for passive and/or active exposure, and 1.64 (95% CI: 1.01–2.61) for passive exposure alone. Smoke exposure was associated with a later age of diagnosis than those with no smoke exposure ( p < 0.001). Conclusion: Prevalence of active and passive smoke exposure was higher in pediatric and adolescent patients with HS compared to age, sex, and race‐matched healthy controls. Smoke exposure increased the odds of having HS and was associated with a later age at diagnosis.
- 9 September 2026
- Published by Wiley in Pediatric Dermatology
Associations of Active and Passive Smoke Exposure and Hidradenitis Suppurativa in the Pediatric Population: A Case–Control Study
Background: Hidradenitis suppurativa (HS) is an inflammatory condition associated with cysts of the folliculopilosebaceous unit primarily affecting intertriginous areas. HS has been correlated with smoke exposure in the adult population, but there is a knowledge gap in understanding its effect in pediatric and adolescent patients. This study assesses correlations between active and passive smoke exposure and the development of HS in the pediatric and adolescent population. Methods: A retrospective case–control study was conducted at Mayo Clinic (2010–2023) of patients diagnosed with HS before the age of 18 years who were age‐, sex‐, and race‐matched to healthy controls in a 1:3 ratio, analyzed using Fisher exact for categorical variables and Kruskal–Wallis for continuous. Results: One hundred and seventy‐four cases and 522 controls met inclusion criteria. The prevalence of active and passive smoke exposure was significantly higher in patients with HS compared to controls ( p = 0.001), with passive smoke accounting for 64.6% ( N = 31/48) of smoke exposure in patients with HS. Smoke exposure was associated with a significant increase in the odds of an HS diagnosis, with an odds ratio of 4.8 (95% CI: 3.06–7.61) for passive and/or active exposure, and 1.64 (95% CI: 1.01–2.61) for passive exposure alone. Smoke exposure was associated with a later age of diagnosis than those with no smoke exposure ( p < 0.001). Conclusion: Prevalence of active and passive smoke exposure was higher in pediatric and adolescent patients with HS compared to age, sex, and race‐matched healthy controls. Smoke exposure increased the odds of having HS and was associated with a later age at diagnosis.
- 13 August 2026
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 28 (1) , 25
Autoinflammatory Syndromes of Hidradenitis Suppurativa: Updates in Clinical Features, Emerging Associations, and Management
- 13 August 2026
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 28 (1) , 25
Autoinflammatory Syndromes of Hidradenitis Suppurativa: Updates in Clinical Features, Emerging Associations, and Management
- Open Access
- 22 July 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
Bimekizumab 2‐year efficacy by hidradenitis suppurativa duration: BE HEARD EXT results
- 22 July 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
Open AccessBimekizumab 2‐year efficacy by hidradenitis suppurativa duration: BE HEARD EXT results
- 1 July 2026
- Published by Wiley in Wound Repair and Regeneration
- Vol. 34 (4)
Use of Wireless Smart Devices in Remote Monitoring of Chronic Wounds: A Scoping Review
The integration of Internet of Things devices in medicine has paved the way for novel diagnostic and therapeutic solutions that offer ‘smart’ capabilities, especially for at‐home wound monitoring. Such capabilities include increasing portability, diminished gaps in care through continuous analysis, and real‐time programmable manipulation of device parameters to intervene more rapidly. This scoping review explores the landscape of Internet of Things devices, including smart bandages, wearable and skin‐interfaced sensors, and mobile app‐connected devices, specifically designed for chronic wound monitoring in a remote, at‐home setting. We reviewed literature from PubMed, IEEE Xplore, Scopus, and Web of Science, using keywords related to Internet of Things and chronic wound care. The evaluation criteria focused on biomarkers analysed, Internet of Things connectivity technology, experimental models used for device validation, and unique device strengths or weaknesses. Our review identified 52 unique studies comprising 77 data entries across five biomarker categories: gas and oxygen saturation, pH, metabolic markers, biophysical parameters of the wound microenvironment, and molecular markers of inflammation or infection. These devices span a wide landscape of biomarkers analysed to predict and monitor wound recovery, with the potential to improve patient outcomes through personalised treatment and timely interventions. However, many devices were never validated clinically on humans and faced limitations in power delivery, accuracy, stability, and reliability that challenge their potential usability in humans for wound monitoring. This review provides a comprehensive understanding of the potential and limitations of Internet of Things devices in at‐home wound care, highlighting areas for future research and development.
- 1 July 2026
- Published by Wiley in Wound Repair and Regeneration
- Vol. 34 (4)
Use of Wireless Smart Devices in Remote Monitoring of Chronic Wounds: A Scoping Review
The integration of Internet of Things devices in medicine has paved the way for novel diagnostic and therapeutic solutions that offer ‘smart’ capabilities, especially for at‐home wound monitoring. Such capabilities include increasing portability, diminished gaps in care through continuous analysis, and real‐time programmable manipulation of device parameters to intervene more rapidly. This scoping review explores the landscape of Internet of Things devices, including smart bandages, wearable and skin‐interfaced sensors, and mobile app‐connected devices, specifically designed for chronic wound monitoring in a remote, at‐home setting. We reviewed literature from PubMed, IEEE Xplore, Scopus, and Web of Science, using keywords related to Internet of Things and chronic wound care. The evaluation criteria focused on biomarkers analysed, Internet of Things connectivity technology, experimental models used for device validation, and unique device strengths or weaknesses. Our review identified 52 unique studies comprising 77 data entries across five biomarker categories: gas and oxygen saturation, pH, metabolic markers, biophysical parameters of the wound microenvironment, and molecular markers of inflammation or infection. These devices span a wide landscape of biomarkers analysed to predict and monitor wound recovery, with the potential to improve patient outcomes through personalised treatment and timely interventions. However, many devices were never validated clinically on humans and faced limitations in power delivery, accuracy, stability, and reliability that challenge their potential usability in humans for wound monitoring. This review provides a comprehensive understanding of the potential and limitations of Internet of Things devices in at‐home wound care, highlighting areas for future research and development.
- 28 May 2026
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 95 (3) , 885-888
Impact of immune checkpoint inhibitors on enfortumab vedotin cutaneous toxicity: A systematic clinicopathologic review
- 28 May 2026
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 95 (3) , 885-888
Impact of immune checkpoint inhibitors on enfortumab vedotin cutaneous toxicity: A systematic clinicopathologic review
- Open Access
- 27 March 2026
- Published by Elsevier in JAAD Case Reports
- Vol. 71, 176-179
Microneedling-induced sarcoidal granulomatous reaction
- 27 March 2026
- Published by Elsevier in JAAD Case Reports
- Vol. 71, 176-179
Open AccessMicroneedling-induced sarcoidal granulomatous reaction
- 21 March 2026
- Published by Springer Nature in Current Dermatology Reports
- Vol. 15 (1) , 4
Harmonizing Hidradenitis Suppurativa: an Updated Glossary of Lesions with Clinical Presentations
- 21 March 2026
- Published by Springer Nature in Current Dermatology Reports
- Vol. 15 (1) , 4
Harmonizing Hidradenitis Suppurativa: an Updated Glossary of Lesions with Clinical Presentations